Hepatitis C Community
13.4k Members
Avatar universal

Hep C and Cannabis Controversy

>Subject: Info About Hep C and Cannabis (letter for your Doc)
>To: ***@****
>The Lifevine Foundation
>2442 NW Market St. #508
>Seattle, WA 98107
>Practicing Physicians
>Medical Professionals
>State of Washington
>Dear Concerned Physician,
>The patient presenting this letter to you has been diagnosed with
>Hepatitis C. The Lifevine Foundation is a non-profit public education
>and legal assistance provider for medical marijuana patients and
>their physicians. We urge you to consider the following information
>when determining whether this patient will potentially benefit from
>the use of cannabis.
>Patients with even mild cases of Hepatitis C often experience
>nonspecific and intermittent symptoms such as nausea and vomiting,
>poor appetite, fatigue, depression, muscle and joint pains, weight
>loss, and mild right-upper-quadrant discomfort or tenderness. These
>symptoms may become more pronounced and chronic as the disease
>As you are probably aware, drug therapy for Hepatitis C usually
>consists of the use of combination therapy with alpha interferon and
>ribavirin in those patients where such therapy is indicated. Common
>side effects of treatment (occurring in more than 10 percent of
>patients) include: nausea and vomiting, depression, irritability,
>weight loss, fatigue, muscle aches, headaches, and low-grade fever.
>Substance abuse relapse is often a common result of the therapy due
>to the psychological side effects. Flare-ups of pre-existing
>auto-immune diseases such as rheumatoid ar
23 Responses
Avatar universal
Flare-ups of pre-existing
>auto-immune diseases such as rheumatoid arthritis, ulcerative colitis
>and Crohn's Disease are common. Marijuana can mitigate the majority
>of these side effects as well as offering effective help to those
>patients where alpha-interferon treatment is not indicated.
>Marijuana (Cannabis) is a powerful antiemetic2, 15, 18 that has been
>shown to be particularly effective controlling nausea and stimulating
>the appetites of immune surpressed patients such as those with HIV or
>undergoing chemotherapy. Cannabis has anti-depressant and
>anti-anxiety properties. It is an anti-inflammatory 3, 4, 6, 9, 10,
>14, 18, 19 and immuno-modulating, 7, 8, 11, 12, agent that can help
>minimize portal inflammation and slow the progression of both
>cirrhosis and Hepatocellular carcinoma. The cannabinoids have been
>shown to be powerful anti-inflammatories and anti-oxidants. They have
>also been shown to have anti-neoplastic activity, at least in gliomas
>(a form of brain cancer). Cannabinoids both slow programmed cell
>death (apoptosis) in normal cells while accelerating apoptosis in
>cancer cells. Cannabis has the added advantage of easing, or even
>completely eliminating, the muscle pains and cramping 1, 2, 5, 17,
>18, 21 that patients often experience. Marijuana is an effective
>analgesic.2, 3, 9, 14,15, 16, 20, 21 Cannabis has also been
>demonstrated as effective with rheumatoid arthritis, MS, and Crohn's.
>4, 7, 8, 20, it can aid in the prevention of inflammation associated
>with flare-ups of these conditions should they be present in your
>patient. Recent studies published this year (2002) have shown that
>cannabinoid receptors throughout the digestive tract act to reduce
>immune-reactivity and to surpress the vagal drive of the digestive
>system, slowing the digestive process, allowing more nutrients to be
>absorbed at a slower rate, thus putting less stress on the liver 1
>The Washington State Medical Quality Assurance Board has included
>Hepatitis C as a debilitating medical condition that could
>potentially benefit from the use of medical marijuana. Please review
>the following reference data. The minimal side effects of cannabis
>will be discussed following the data.
>Published Reference Data (Studies relevant to Hepatitis C, short
>synopsis - complete articles are available. Other references are
>located following the conclusion of this report.)
>1. Adami, Frati, Bertini, Kulkarni-Narla, Brown, de Caro, Coruzzi,
>and Soldani, "Gastric antisecretory role and immunohistochemical
>localization of cannabinoid receptors in the rat stomach" British
>Journal of Pharmacology Vol. 135, 2002, The study found cannabinoid
>receptors throughout the gastrointestinal organs of rats.
>"Immunoreactivity to the CB1 receptor was co-localized with that of
>the cholinergic marker choline acetyltransferase in neural elements
>innervating smooth muscle, mucosa and submucosal blood vessels of rat
>stomach fundus, corpus and antrum. These results indicate that
>gastric antisecretory effects of cannabinoids in the rat are mediated
>by suppression of vagal drive to the stomach through activation of
>CB1 receptors, located on pre- and postganglionic cholinergic
>2. Baron and Folan, "Ulcerative Colitis and Marijuana", Annals of
>Internal Medicine, Vol. 112, No.6, p 47, 1990, "The symptoms of
>ulcerative colitis were repeatedly relieved by smoked cannabis."
>3. Beltramo and Piomelli, "Functional role of high-affinity
>anandamide transport as revealed by selective inhibition." Science,
>Vol.277, No. 5329, pp1094, 1997, "Cannabinoid and non-cannabinoid
>compounds in marijuana reduce pain and inflammation."
>4. BW Healthwire, January 1998, "Pre-clinical studies show CT-3
>reduces chronic and acute inflammation and reduces destruction of
>joints." Atlantic Pharmaceuticals was evaluating CT-3, a cannabinoid
>derivative. The company reported "In recent studies, the agent was
>found to reduce inflammation and prevent the destruction of joint
>5. Egli, Elsohly, Henn and Spiess. International Journal of Clinical
>Pharmacology, Vol. 34, No. 10, pp46-452, 1988, "The effect of orally
>and rectally administered delta-9-tetrahydrocannabinol on spasticity"
>"THC was shown to relieve muscle spasms in human patients."
>6. Formukong, Evans, and Evans "Analgesic and anti-inflammatory
>activity of constituents of cannabis sativa l" Inflammation, Vol. 12
>No. 4, pp361-371, 1988, "Cannabidol is more effective than aspirin in
>reducing inflammation" (Cannabidol or CBD, is one of the scores of
>cannibinoids found in marijuana other than THC)
>7. Friedman, H.; Klein, T.W.; Newton, C.; and Daaka, Y., "Marijuana
>receptors and immunomodulation." Advances in Experimental Medicine
>and Biology 373: pp103-113, 1995, "The study suggested that the
>immunosuppressive effects of cannabinoids might be useful clinically;
>for example, in treating multiple sclerosis.
>8. Grotenhermen Dr. Franjo, IACM-Bulletin of 25 June 2000, (IACM):
>"We know from animal studies that THC inhibits the production of Th-1
>cytokines such as IL-1, IL-2, and IFN-gamma and stimulates the
>production of Th-2 cytokines such as IL-4, IL-10, and TGF-beta. This
>would give reason for a causal therapeutic use of THC in certain
>autoimmune diseases that appear to be Th-1 mediated such as Crohn's
>disease, a form of chronic intestinal inflammation, and rheumatoid
>9. Holdcroft, et al., "Pain relief with oral cannabinoids in familial
>Mediterranean fever" Anesthesia, Vol. 52, No. 5, May 1997. This
>research paper done at Hammersmith Hospital in London confirmed
>cannabis' analgesic effects in the first UK clinical trial. The paper
>states "Cannabinoids have analgesic and possibly anti-inflammatory
>properties but their clinical use has been restricted by legislation"
>10. Hollister L.E, "Health Aspects of Marijuana" Pharmacological
>Review, Vol. 38, No. 1, 1986, "Constituents of marijuana; CBC,
>olivitol, and cannoflavin all have marked anti-inflammatory
>11. Hollister L.E, "Marijuana and immunity" Journal of Psychoactive
>Drugs Vol.20 (1: 3-8, January-March, 1988, Cannabinoids found in
>marijuana are effective immunomodulators.
>12. Kaminsky N. E., "Evidence for a cannabinoid receptor in
>immunomodulation by cannabinoid compounds" Advances in Experimental
>Medicine and Biology, Vol. 335, 115-120, 1993, Identifies the
>receptors and process that allows marijuana to be an effective
>13. Kaminsky N. E. Journal of Neuroimmunology, 1998, "These
>[cannabinoids] might be useful as immune modulators, perhaps to be
>used as anti-inflammatory agents"
>14. Maurer, Henn, Dietrich and Hoffmann "Delta-9-tetrahydrocannibinol
>shows anti-spastic and analgesic effects in a single case
>double-blind trial" European Archive of Psychiatry and Neurological
>Science, Vol. 240 No. 1 pp1-4 1990, The trial compared Codeine, THC,
>and a placebo. The study found codeine and THC had comparable
>analgesic effects but only THC had a significant beneficial effect on
>spasticity and inflammation."
>15. National Academy of Science, Institute of Medicine, "Marijuana
>and Medicine; Assessing the Science Base " Executive Summary, 1999,
>"Conclusion: Scientific data indicate the potential therapeutic value
>of cannabinoid drugs, primarily THC, for pain relief, control of
>nausea and vomiting, and appetite stimulation;"
>16. Noyes and Barnes, Comprehensive Psychiatry, Vol. 15, No. 6, pp
>413s-416s, 1974, "There are indications that the active ingredients
>in marijuana may be an effective analgesic that is efficacious in
>functional pain"
>17. Petro and Ellenberger, "Treatment of human spasticity with
>delta-9-tetrahrdrocannibinol" Journal of Clinical Pharmacology, Vol.
>21, 1981, "THC can relieve a broad range of muscle spasms in humans
>and animals"
>18. Pharmos Corporation Press Release, May 21 1998, Researchers
>reported that experimental treatment of rats suffering from
>ulcerative colitis with Dexanabinol (synthetic cannabidiol-CBD)
>"significantly reduced the anorexia and the colonic inflammation
>associated with this condition compared with untreated rats."
>19. Richardson, Kilo, & Hargreaves, "Cannabinoids Reduce Hyperalgesia
>and Inflammation via Interaction with Peripheral CB1 Receptors". Pain
>Vol. 75, 1 pp. 111-119, 1998, Conclusion is in title.
>20. Society for Neuroscience Conference, symposium syllabus,
>Functional Role of Cannabinoid Receptors, Aug. '98, "Cannabinoids
>were shown to have a direct effect on the biochemical pain signals in
>the central nervous system, and to exhibit superior pain control to
>addictive opiate based narcotics. Cannabinoids prevented hyperalgia
>and were shown to be particularly effective in the treatment of
>arthritis and other inflammation induced pain.
>21. Zeltser, R.; Seltzer, Z.; Eisen, A.; Feigenbaum, J.J.; and
>Mechoulam, R "Suppression of neuropathic pain behavior in rats by a
>non-psychotropic synthetic cannabinoid with NMDA receptor-blocking
>properties" Pain Vol. 47(1): 95-103, October. 1991, The study found
>cannabis surpressed neuropathic pain which complicates many CNS
>diseases. Cannabis was effective when few available therapies
>provided even partial relief.
>Historical Data
>*The oldest medical text known to man was written over 5,000 years
>ago. The Chinese Pen Ts'ao, prescribed cannabis for rheumatism and
>digestive disorders among other illnesses.
>*The New English Dispensary of 1764 recommended hemp to reduce
>*In 1814, Nicholas Culpepper published his Complete Herbal, which
>included "allaying humors of the bowels" and "reducing inflammation"
>among the applications of cannabis.
>*Surgeon William O'Shoughnessy in his 1839 paper titled On the
>preparation of the Indian Hemp found that cannabis relieved
>rheumatism, convulsions and muscle spasms.
>*The 1854 United States Dispensatory listed many uses for cannabis
>including "reduction of inflammation", "relax muscle contractions",
>"treatment of digestive disorders" and as "an analgesic and sedative"
>*Between 1840 and 1890 over 100 papers were published on the medical
>uses of cannabis.
>*Sir William Osler, known as the "father of modern medicine",
>proclaimed cannabis the best treatment for migraine pain in his
>authoritative 1915 textbook.
>*In 1937, when the Marijuana Tax Act was before Congress The American
>Medical Association protested vehemently, Dr William C. Woodward, the
>AMA's counsel, testified that the bill would deprive Americans of one
>of the most useful drugs known to medicine. He also complained that
>the only reason there hadn't been a larger public outcry was because
>the Act referred to the Mexican slang "marijuana" and not to
>cannabis, which everyone understood was a medicine
>Side Effects
>There has never been a reported death from overdose of marijuana 10,
>15, 22, 23, 26 27. There has never been a death or permanent health
>effect reported from long-term heavy use of marijuana 10, 22, 23, 27.
>Side effects include; a slight increase in heart rate24, 25, slight
>hypotension24, 25, increased appetite 15, 24, and of course, a mild
>euphoric effect. There are "no deleterious effects on the normal
>cardiovascular system" as a result of these side effects according to
>a 1997 WHO report27,. An Australian National Drug Strategy report
>states "Tolerance to the cardiovascular effects develop within 7-10
>days in persons receiving daily doses of THC" 24,.
>The euphoria also is subject to the effects of tolerance. Any effects
>on coordination and cognition dissipate within 7-10 days of daily
>use15, 24. However marijuana's effects continue to aid with the
>patient's stress reduction and to alleviate the depression and other
>emotional problems that Hepatitis C patients often suffer from 10,
>15, 28, 29, 30. Many patients find cannabis far superior to Valium,
>Serax, Elavil, or Sinequan; all are commonly prescribed to Hepatitis
>C sufferers. Please contact the Lifevine Foundation for published
>data regarding the anti-anxiety and anti-depressant properties of
>cannabis. Hepatitis C patients find the appetite stimulation10, 15,
>31, an added benefit. It is likely that your patient has already
>tried marijuana for their symptoms and feels the perceived benefits
>outweigh any side effects they have experienced.
>The most obvious risk of smoking marijuana, is, of course, the risk
>incurred smoking any vegetable material. There are several factors to
>consider when determining this risk. If your patient is not suffering
>from malabsorbtion due to their Hepatitis C and they are able to keep
>food digesting for two hours, the patient may choose to eat their
>cannabis and avoid all smoking risks. Other smoking methods such as
>vaporizers (which heat the cannabis to a temperature high enough to
>"vaporize" the cannabinoids on the surface of the marijuana without
>igniting the vegetable matter) may minimize the smoking risks.
>The carcinogenic ingredients in both tobacco and cannabis are
>primarily the tars that reside in both plants - not the THC or other
>cannabinoids of cannabis. The main difference in the incidence of
>development of lung cancer is a matter of exposure to these tars,
>which is overwhelmingly greater with tobacco than with cannabis.
>It takes 20 - 25 pack/years or more (1 pack/year == smoking 1 pack of
>cigarettes/day for 1 year.) for most tobacco-induced lung cancers to
>develop. 20 - 25 pack/years worth of cigarettes == 150,000 to 200,000
>cigarettes. Of all those people who smoke 1 pack/day or more of
>tobacco cigarettes for all of their adult lives, only 1 in 5 (20%)
>will actually develop tobacco-induced lung cancer.
>Most patients who use marijuana medicinally develop their illness in
>mid to late life, and start smoking marijuana medicinally only when
>their projected remaining life span is already relatively short.
>Light medical marijuana users - (1-2 joints/day) in one year would
>smoke 365 - 730 joints; In ten years - 3650 - 7300 joints. In order
>to reach the equivalent of 200,000 cigarettes it would take them 270
>years, at which time 1/5 of them might develop a cancer.
>Very heavy use of medicinal marijuana may amount to 10 joints/day. In
>one year they would smoke roughly 3,650 joints; in ten years- 36,500
>joints It would take them 54 years to smoke the equivalent of 200,000
>tobacco cigarettes, at which time 1/5 of them might develop a cancer.
>These figures assume large (1 gm) joints are being smoked - similar
>in size to a tobacco cigarette
>Tobacco smoke is a bronchial constrictor known to penetrate the
>lung's smaller peripheral air passages and causes inflammation of the
>lung's absorbent microphages. Tobacco causes blockages which leads to
>emphysema. Dr. Donald Tashkin, a federally sponsored pulmonologist
>and professor of medicine at UCLA Medical School has determined that
>marijuana smoke acts as a bronchial dilator and surpresses
>inflammation of the lung's macrophages. In a 1997 UCLA study
>involving 394 participants32 Tashkin noted "Neither habitual
>long-term marijuana smokers nor intermittent marijuana smokers
>exhibited any significantly different rates of decline in lung
>function. No differences were noted between even quite heavy smoking
>and non-smoking of marijuana." In contrast, the tobacco-only smokers
>in the study experienced a rapid decline in lung function during the
>eight years this study ran. The study also found no connection
>between marijuana and tobacco smoking in those s ubjects who smoked
>both. The evidence from this exhaustive real-world study indicates
>that the pulmonary health of marijuana smokers is no different from
>that of the general population.
>In an article in American Journal of Respiratory Cellular and
>Molecular Biology 2001 Mar; 24(3): 339-44 titled "Induction and
>regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana
>smoke and delta (9) tetrahydrocannabinol" by the Roth et al, Division
>of Pulmonary and Critical Care Medicine, Department of Pathology and
>Laboratory Medicine, UCLA School of Medicine, "Induction of the
>carcinogen-metabolizing enzyme cytochrome P4501A1 (CYP1A1) is a key
>step in the development of tobacco-related cancers." They determined
>THC had a significant inhibitory effect on the cancer-causing
>enzyme's induction into the body.
>Other tests conducted by Dr. Tashkin at UCLA have found a slightly
>higher risk of bronchitis and other upper respiratory infections in
>marijuana smokers33. This risk may be mitigated by the use of
>vaporizers or by the use of ice or water-cooled pipes
>Other risks include physical or psychological dependence. These risks
>are far lower than with any other psychotropic drug15. The addictive
>properties of marijuana are less than caffeine, ephedrine, or
>benzodiazepines (like Valium).15 Marijuana is similar to chocolate in
>it's potential for dependency34. Unlike alcohol, nicotine, opiates,
>barbiturates, amphetamines, cocaine or chocolate, marijuana does not
>effect the dopamine receptors of the brain35, 36. There is no
>physical withdrawal10, 15, 26, 27,36. Unlike steroids and other
>pharmaceuticals, one can cease use immediately; there is no need to
>"taper down" dosages.
>There is compelling evidence that cannabis is an effective
>antiemetic, anti-inflammatory, immune modulating, analgesic and anti
>spasmodic agent. These properties are indicated for patients
>suffering from Hepatitis C. Five thousand years of recorded medical
>of use, has shown no long-term consequences. Side effects from the
>use of medical marijuana are much milder than the side effects of the
>traditional drugs used to treat Hepatitis C. Many patients who use
>cannabis report they are able to continue the use of their
>prescription medications only when the side effect can be mitigated
>with cannabis. Marijuana also has recognized anti-anxiety,
>anti-depressant and stress reducing qualities which ease
>psychological symptoms and side effects as well as helping to prevent
>substance abuse relapse. Cannabis has the ability to stimulate
>appetite, which many Hepatitis C patients find beneficial. Patients
>without prescription insurance find the ability to grow their own
>medicine at li ttle or no cost to be an additional benefit.s
>RCW 69.51A states that for a patient to qualify for use of medical
>marijuana, their physician must find that "It is their medical
>opinion that the potential benefits of the medical use of marijuana
>would likely outweigh the health risks for this patient." We urge you
>to sign the enclosed "Documentation of Medical Authorization to
>Possess Marijuana for Medical Purposes in Washington State." The
>Washington State Medical Association has prepared this document for
>use by our state's physicians. The link between stress and Hepatitis
>C is well established. Eliminating the stress induced by the fear of
>arrest by patients who currently use marijuana for their symptoms is
>yet one more benefit of the medical marijuana act.

>Other Published reference data
>22. Mechoulam R. 1986. The pharmacology of cannabis sativa. In
>Cannabinoids as Therapeutic Agents, ed. R Mechoulam, pp. 1
Avatar universal
Gosh Guys...I am sorry that this is so long. I just got it via email this morn and remmembered..there was some discussion on this earlier. Thought this might be interesting. I hope you are all well. Haven't been reading the threads lately...burying myself under the covers these days...but only 5 weeks left. Even though I'm not checking in much lately, my thoughts and prayers are with you all.take care my family, love, kim
26471 tn?1211940121
Hey, I'm convinced!
Avatar universal
I'm not even on tx anymore and I can't sit still long enough to read all that ;)
Avatar universal
In a nutshell, whats it all about Alfie?
Avatar universal
The potential to have a positive effect on side effects is not the issue. There are questions regarding the negative impact on liver histology and propgression of fibrosis.

That is not even addressed in this study.

Have an Answer?
Top Hepatitis Answerers
317787 tn?1473362051
683231 tn?1467326617
Auburn, WA
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Answer a few simple questions about your Hep C treatment journey.

Those who qualify may receive up to $100 for their time.
Explore More In Our Hep C Learning Center
image description
Learn about this treatable virus.
image description
Getting tested for this viral infection.
image description
3 key steps to getting on treatment.
image description
4 steps to getting on therapy.
image description
What you need to know about Hep C drugs.
image description
How the drugs might affect you.
image description
These tips may up your chances of a cure.
Popular Resources
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Here’s how your baby’s growing in your body each week.
These common ADD/ADHD myths could already be hurting your child
This article will tell you more about strength training at home, giving you some options that require little to no equipment.
In You Can Prevent a Stroke, Dr. Joshua Yamamoto and Dr. Kristin Thomas help us understand what we can do to prevent a stroke.
Smoking substitute may not provide such a healthy swap, after all.